Drugs in Pipeline
6
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Mar 15, 2026
| Drug Name | Phase |
|---|---|
TransCon hGH | Phase 3 |
ACP-001 (TransCon hGH) | Phase 2 |
ACP-001 | Phase 2 |
Navepegritide | Phase 2 |
Placebo for Navepegritide | Phase 2 |
TransCon CNP | Phase 2 |
2 upcoming, 0 past
Primary completion for Placebo for Navepegritide trial (NCT06079398) in Achondroplasia
SourcePrimary completion for Navepegritide trial (NCT06079398) in Achondroplasia
Source